Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Drug discovery

Facebook Twitter LinkedIn Email Comments
Promega_DrugDiscovery.jpgIssue 20 of “Cell Notes,” a serial publication of Promega Corp., focuses on drug discovery and screening. The 32-page document includes an article on monitoring viability during gene-directed enzyme prodrug therapy with the CellTiter-Glo assay and human neural progenitor cells, and a discussion on detecting toxicological responses in cells with the bioluminescent GSH-Glo glutathione assay. Other articles address screening traditional Chinese medicines, RNAi knockdown in primary cells, cytochrome P450 activity in rat hepatocytes cultured on a synthetic extracellular matrix, and high-throughput kinase and multiplex cytotoxity assays. Publications that cite the use of Promega reagents and technologies in novel high-throughput screening applications are highlighted.

May 2008
BiophotonicsBreakthroughMediacellsenzyme prodrug therapyNew MediaPromega Corp.toxicological responses

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.